Amgen abandons candidates for cancer, Sjögren’s syndrome over weak ph. 2 data
Amgen abandons candidates for cancer, Sjögren’s syndrome over weak ph. 2 data
本文は利用できません。元の情報源をご確認ください。
Amgen abandons candidates for cancer, Sjögren’s syndrome over weak ph. 2 data
A compact weekly email covering company moves, product signals, regulatory updates, and notable funding.